vs
Side-by-side financial comparison of FENNEC PHARMACEUTICALS INC. (FENC) and INTERGROUP CORP (INTG). Click either name above to swap in a different company.
INTERGROUP CORP is the larger business by last-quarter revenue ($17.3M vs $13.8M, roughly 1.3× FENNEC PHARMACEUTICALS INC.). INTERGROUP CORP runs the higher net margin — 8.8% vs -34.7%, a 43.5% gap on every dollar of revenue. On growth, FENNEC PHARMACEUTICALS INC. posted the faster year-over-year revenue change (73.8% vs 19.8%). Over the past eight quarters, INTERGROUP CORP's revenue compounded faster (7.8% CAGR vs -26.3%).
Fennec Pharmaceuticals Inc. is a biopharmaceutical firm focused on developing and commercializing therapies to reduce treatment-related side effects in pediatric cancer patients. Its lead product targets chemotherapy-induced ototoxicity, with core North American markets serving oncology providers and vulnerable pediatric patient groups.
Intergroup Corp is a diversified holding firm operating two core segments: real estate and hotel operations. It owns, manages and leases commercial and residential properties across the U.S., and runs limited-service hotels for leisure and business travelers.
FENC vs INTG — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $13.8M | $17.3M |
| Net Profit | $-4.8M | $1.5M |
| Gross Margin | — | — |
| Operating Margin | -18.5% | 11.6% |
| Net Margin | -34.7% | 8.8% |
| Revenue YoY | 73.8% | 19.8% |
| Net Profit YoY | -141.1% | 155.6% |
| EPS (diluted) | $-0.17 | $0.71 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $13.8M | $17.3M | ||
| Q3 25 | $12.5M | $17.9M | ||
| Q2 25 | $9.7M | $16.2M | ||
| Q1 25 | $8.8M | $16.8M | ||
| Q4 24 | $7.9M | $14.4M | ||
| Q3 24 | $7.0M | $16.9M | ||
| Q2 24 | $7.3M | $13.4M | ||
| Q1 24 | $25.4M | $14.9M |
| Q4 25 | $-4.8M | $1.5M | ||
| Q3 25 | $-638.0K | $-535.0K | ||
| Q2 25 | $-3.2M | $-2.2M | ||
| Q1 25 | $-1.2M | $-578.0K | ||
| Q4 24 | $-2.0M | $-2.7M | ||
| Q3 24 | $-5.7M | $-398.0K | ||
| Q2 24 | $-5.6M | $-4.9M | ||
| Q1 24 | $12.8M | $-3.2M |
| Q4 25 | -18.5% | 11.6% | ||
| Q3 25 | -1.5% | 15.3% | ||
| Q2 25 | -28.3% | 8.1% | ||
| Q1 25 | -9.2% | 14.0% | ||
| Q4 24 | -11.8% | 5.9% | ||
| Q3 24 | -74.6% | 18.5% | ||
| Q2 24 | -69.4% | 3.7% | ||
| Q1 24 | 54.2% | 4.8% |
| Q4 25 | -34.7% | 8.8% | ||
| Q3 25 | -5.1% | -3.0% | ||
| Q2 25 | -32.7% | -13.9% | ||
| Q1 25 | -13.3% | -3.4% | ||
| Q4 24 | -25.0% | -18.9% | ||
| Q3 24 | -82.2% | -2.4% | ||
| Q2 24 | -76.5% | -36.7% | ||
| Q1 24 | 50.6% | -21.3% |
| Q4 25 | $-0.17 | $0.71 | ||
| Q3 25 | $-0.02 | $-0.25 | ||
| Q2 25 | $-0.11 | — | ||
| Q1 25 | $-0.04 | $-0.27 | ||
| Q4 24 | $-0.02 | $-1.26 | ||
| Q3 24 | $-0.21 | $-0.18 | ||
| Q2 24 | $-0.20 | — | ||
| Q1 24 | $0.41 | $-1.44 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $36.8M | $7.5M |
| Total DebtLower is stronger | — | $233.2M |
| Stockholders' EquityBook value | $35.5M | $-85.2M |
| Total Assets | $70.6M | $101.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $36.8M | $7.5M | ||
| Q3 25 | $21.9M | $6.0M | ||
| Q2 25 | $18.7M | $6.1M | ||
| Q1 25 | $22.7M | $4.8M | ||
| Q4 24 | $26.6M | $15.4M | ||
| Q3 24 | $40.3M | $12.2M | ||
| Q2 24 | $43.1M | $11.6M | ||
| Q1 24 | $51.2M | $19.5M |
| Q4 25 | — | $233.2M | ||
| Q3 25 | $19.4M | $237.8M | ||
| Q2 25 | $19.4M | $240.5M | ||
| Q1 25 | $19.4M | $241.5M | ||
| Q4 24 | $19.3M | $227.2M | ||
| Q3 24 | $32.1M | $218.1M | ||
| Q2 24 | $31.8M | $225.7M | ||
| Q1 24 | $31.3M | $225.0M |
| Q4 25 | $35.5M | $-85.2M | ||
| Q3 25 | $-4.5M | $-86.7M | ||
| Q2 25 | $-7.5M | $-86.1M | ||
| Q1 25 | $-5.9M | $-84.5M | ||
| Q4 24 | $-5.9M | $-83.9M | ||
| Q3 24 | $-5.2M | $-80.9M | ||
| Q2 24 | $-1.4M | $-80.3M | ||
| Q1 24 | $3.0M | $-76.4M |
| Q4 25 | $70.6M | $101.1M | ||
| Q3 25 | $49.3M | $102.5M | ||
| Q2 25 | $44.9M | $104.1M | ||
| Q1 25 | $46.4M | $103.2M | ||
| Q4 24 | $44.9M | $110.6M | ||
| Q3 24 | $58.9M | $109.3M | ||
| Q2 24 | $63.2M | $107.8M | ||
| Q1 24 | $69.2M | $119.0M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 10.40× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-6.0M | $-23.0K |
| Free Cash FlowOCF − Capex | — | $-481.0K |
| FCF MarginFCF / Revenue | — | -2.8% |
| Capex IntensityCapex / Revenue | — | 2.6% |
| Cash ConversionOCF / Net Profit | — | -0.02× |
| TTM Free Cash FlowTrailing 4 quarters | — | $739.0K |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-6.0M | $-23.0K | ||
| Q3 25 | $1.5M | $-296.0K | ||
| Q2 25 | $-3.7M | $5.9M | ||
| Q1 25 | $-4.3M | $-854.0K | ||
| Q4 24 | $-1.5M | $-781.0K | ||
| Q3 24 | $-2.2M | $3.4M | ||
| Q2 24 | $-8.4M | $6.8M | ||
| Q1 24 | $39.0M | $1.9M |
| Q4 25 | — | $-481.0K | ||
| Q3 25 | — | $-1.3M | ||
| Q2 25 | — | $3.6M | ||
| Q1 25 | — | $-1.2M | ||
| Q4 24 | — | $-1.1M | ||
| Q3 24 | — | $3.1M | ||
| Q2 24 | — | $2.7M | ||
| Q1 24 | — | $1.1M |
| Q4 25 | — | -2.8% | ||
| Q3 25 | — | -7.1% | ||
| Q2 25 | — | 22.5% | ||
| Q1 25 | — | -6.8% | ||
| Q4 24 | — | -7.8% | ||
| Q3 24 | — | 18.3% | ||
| Q2 24 | — | 20.4% | ||
| Q1 24 | — | 7.6% |
| Q4 25 | — | 2.6% | ||
| Q3 25 | — | 5.4% | ||
| Q2 25 | — | 13.9% | ||
| Q1 25 | — | 1.8% | ||
| Q4 24 | — | 2.4% | ||
| Q3 24 | — | 1.6% | ||
| Q2 24 | — | 30.4% | ||
| Q1 24 | — | 4.9% |
| Q4 25 | — | -0.02× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 3.04× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FENC
Segment breakdown not available.
INTG
| Hotel Operations | $12.7M | 73% |
| Real Estate Operation | $4.6M | 27% |
